Clinical trial
Combination Chemotherapy Followed by Surgery in Treating Patients With Localized…
NCT00017563 · OHSU Knight Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00017563 |
|---|---|
| Title | Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer |
| Official title | Phase I/II Study of Neoadjuvant Weekly Docetaxel and Mitoxantrone Prior to Prostatectomy in Patients With High Risk Localized Prostate Cancer |
| Lead sponsor | OHSU Knight Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Procedure |
| Interventions | docetaxel, mitoxantrone hydrochloride, conventional surgery |
| Enrollment | 57 |
| Start date | Sep 1, 2000 |
| Primary completion | May 1, 2010 |
| First posted | Jan 27, 2003 |
| Last update posted | Apr 28, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: